$23.760
-0.238 (-1.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DNLI Prediction & Forecast by Similar Chart Analysis
Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.63 (-0.56%). The 1-week path is $23.66 (-0.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Denali Therapeutics Inc Stock?
Denali Therapeutics Inc (DNLI) is a good buy right now due to its recent revenue growth of $3.6 million in Q2 2026, which exceeded expectations by $1.41 million, and a gross margin of 76.61%, indicating strong profitability potential. However, the main risk is the negative net income margin of -3539.21%, which reflects ongoing losses that investors should consider.
DNLI stock price ended at $23.76 on Monday, after losing -1.00%
Denali Therapeutics Inc (DNLI) last closed at $23.76, losing -1.00%. These facts feed the 1-day and 1-week DNLI price prediction above.
Analyst Consensus
Denali Therapeutics Inc (DNLI): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Denali Therapeutics Inc (DNLI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches DNLI, ranked by similarity.
Seasonality analysis for DNLI
Historically the probability of a positive September return for DNLI is 50.00%. August offers the highest probability of a positive month at 67.19%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.